当前位置: 首页 > 详情页

Comparison of different endovascular treatments of femoropopliteal artery in-stent restenosis:a systematic review and Bayesian network meta-analysis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China. [2]Division of Vascular and Endovascular Surgery, University of Trieste, Trieste, Italy
出处:
ISSN:

摘要:
This Bayesian network meta-analysis sought to evaluate the efficacy of different endovascular treatments for femoropopliteal in-stent restenosis (FP-ISR).PubMed, Embase, Cochrane Central Register of Controlled Trials and Web of science for clinical trials from database inception to 31 March 2023, with no language restrictions to retrieve randomized controlled trials (RCTs) or cohort studies evaluating the impact of any kind of endovascular treatments for FP-ISR. Pair-wise meta-analysis and Bayesian network meta-analysis were performed to pool the outcome estimates different endovascular treatments. The primary endpoints under consideration were primary patency rates at both 6- and 12-month follow up.A total of 15 studies with 1424 patients were ultimately enrolled to be analyzed, 7 types of endovascular treatment were identified for comparison. In terms of primary patency and freedom from target lesion revascularization (F-TLR) at 6-,12-month follow-up, the direct meta-analysis findings showed that drug coated balloons (DCB) and CS are considerably superior to plain old balloon angioplasty (POBA), Excimer laser atherectomy (ELA)+DCB is significantly better than DCB. According to the meta-analysis based on Bayesian theory, during the 6-,12-months follow-up, we couldn't find significant difference between the different treatments in terms of the primary patency and the freedom from TLR, based on the surface values under the cumulative ranking curve (SUCRA), CS was considered the best treatment in terms of primary patency(6 months SUCRA=85.2; 12 months SUCRA=78.9) and freedom from TLR(6 months SUCRA=84.9; 12 months SUCRA=70.9); directional atherectomy (DA)+POBA may lead to higher survival rate at 12 months(SUCRA=89.1) than others treatments; in addition, both ELA+POBA and ELA+DCB have higher limb salvage than POBA.The findings of this network meta-analysis suggest that CS showed positive encouraging results in primary patency and TLR in femoropopliteal ISR at 6, 12 months. However, due to the potential influence of certain confounding factors, the long-term results necessitate validation through numerous RCTs.Copyright © 2024 Elsevier Inc. All rights reserved.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 外周血管病 4 区 外科
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 外周血管病 4 区 外科
JCR分区:
出版当年[2022]版:
Q3 SURGERY Q4 PERIPHERAL VASCULAR DISEASE
最新[2023]版:
Q3 PERIPHERAL VASCULAR DISEASE Q3 SURGERY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
通讯作者:
通讯机构: [1]Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China. [*1]Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing 100053, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院